The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pan-cancer analysis of exogenous (microbial) sequences in tumor transcriptome data from the ORIEN consortium and their association with cancer and tumor microenvironment.
 
Daniel Spakowicz
No Relationships to Disclose
 
Rebecca Hoyd
No Relationships to Disclose
 
Caroline E. Wheeler
No Relationships to Disclose
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Janssen; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Rebecca D. Dodd
No Relationships to Disclose
 
Jennifer Ose
No Relationships to Disclose
 
Sheetal Hardikar
No Relationships to Disclose
 
Ahmad A. Tarhini
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clinigen Group; Eisai; Genentech/Roche; Instil Bio; Merck; Novartis; Partner Therapeutics; Sanofi/Regeneron
Research Funding - Acrotech Biopharma (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Genentech/Roche (Inst); InflaRx (Inst); Merck (Inst); OncoSec (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst)
 
Lary A. Robinson
No Relationships to Disclose
 
Eric A. Singer
Consulting or Advisory Role - Johnson & Johnson/Janssen; Merck; Vyriad
Research Funding - Astellas Medivation
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Bristol Meyer Squibb; Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
Other Relationship - M2Gen
 
Carlos Hou Fai Chan
Research Funding - AngioDynamics; Checkmate Pharmaceuticals
 
Alexandra Ikeguchi
No Relationships to Disclose
 
Cornelia M Ulrich
No Relationships to Disclose
 
Martin McCarter
Research Funding - Merck; Taiho Pharmaceutical
Other Relationship - Debbies Dream Foundation